Giuseppe Montalto Selected Research

morpholinopropane sulfonic acid (MOPS)

1/2021	NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response.
12/2020	Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Montalto Research Topics

Disease

61	Neoplasms (Cancer) 01/2022 - 07/2002
42	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 06/2002
15	Liver Neoplasms (Liver Cancer) 01/2018 - 07/2002
13	Liver Diseases (Liver Disease) 11/2021 - 01/2003
12	Inflammation (Inflammations) 12/2020 - 01/2003
12	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020 - 05/2012
11	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 02/2009
11	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2013
11	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015 - 03/2003
10	Body Weight (Weight, Body) 01/2021 - 12/2010
10	Atherosclerosis 01/2018 - 07/2012
8	Cardiovascular Diseases (Cardiovascular Disease) 04/2021 - 07/2012
8	Dyslipidemias (Dyslipidemia) 04/2021 - 01/2013
8	Insulin Resistance 01/2017 - 01/2013
7	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2012
7	Carcinogenesis 01/2014 - 12/2004
6	Diabetes Mellitus 09/2020 - 04/2006
6	Obesity 01/2017 - 12/2002
6	Celiac Disease (Celiac Sprue) 04/2007 - 04/2002
5	Non-alcoholic Fatty Liver Disease 12/2020 - 06/2014
5	Fibrosis (Cirrhosis) 01/2020 - 12/2017
4	Adenocarcinoma 01/2022 - 01/2017
4	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2014
4	Fatty Liver 01/2021 - 11/2007
4	Infections 01/2020 - 01/2004
4	Chronic Hepatitis C 11/2007 - 01/2003
3	Hepatitis 01/2020 - 06/2004
3	Overweight 01/2014 - 12/2002
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

12	oxidized low density lipoproteinIBA 04/2021 - 07/2012
12	LipidsIBA 05/2020 - 01/2013
10	Pharmaceutical PreparationsIBA 05/2020 - 04/2006
9	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 09/2007
8	Liraglutide FDA Link 01/2021 - 02/2014
8	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 01/2013
8	Triglycerides (Triacylglycerol)IBA 01/2017 - 07/2007
7	BerberineIBA 01/2022 - 12/2012
7	LDL CholesterolIBA 04/2021 - 01/2013
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2004
7	Glycogen Synthase Kinase 3IBA 01/2021 - 05/2014
7	CholesterolIBA 10/2020 - 12/2002
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2020 - 03/2013
6	Metformin (Glucophage)FDA LinkGeneric 09/2020 - 02/2014
6	Biomarkers (Surrogate Marker)IBA 05/2020 - 04/2010
6	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 09/2013
6	Lipoproteins (Lipoprotein)IBA 01/2018 - 07/2012
6	EnzymesIBA 02/2009 - 04/2002
5	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 10/2012
5	Interleukin-6 (Interleukin 6)IBA 10/2020 - 04/2006
5	Biological ProductsIBA 12/2012 - 12/2004
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2011 - 12/2004
4	Messenger RNA (mRNA)IBA 12/2020 - 02/2009
4	IncretinsIBA 09/2020 - 07/2013
4	Antiviral Agents (Antivirals)IBA 10/2018 - 06/2004
4	beta CateninIBA 02/2017 - 05/2004
4	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2016 - 01/2014
4	Hormones (Hormone)IBA 01/2016 - 07/2002
4	Therapeutic UsesIBA 06/2014 - 12/2004
4	Celecoxib (Celebrex)FDA Link 01/2013 - 04/2010
4	Cyclooxygenase 1IBA 02/2009 - 02/2006
4	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2007 - 12/2004
4	TransglutaminasesIBA 04/2007 - 04/2002
4	Interferon-alpha (Interferon Alfa)IBA 06/2004 - 01/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020 - 07/2007
3	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 08/2012
3	Estrogen ReceptorsIBA 01/2020 - 03/2011
3	InterferonsIBA 11/2019 - 01/2003
3	Mechanistic Target of Rapamycin Complex 1IBA 11/2019 - 07/2014
3	Transaminases (Aminotransferases)IBA 10/2019 - 01/2003
3	Proteasome InhibitorsIBA 01/2018 - 05/2004
3	CurcuminIBA 01/2018 - 11/2006
3	Protein Isoforms (Isoforms)IBA 01/2017 - 02/2006
3	HDL CholesterolIBA 01/2017 - 01/2013
3	NF-kappa B (NF-kB)IBA 09/2015 - 11/2006
3	Fibric Acids (Fibrates)IBA 06/2014 - 01/2013
3	Insulin (Novolin)FDA Link 06/2014 - 01/2013
3	SurvivinIBA 05/2011 - 12/2004
3	Transcription Factors (Transcription Factor)IBA 05/2011 - 11/2006
3	Estrogens (Estrogen)FDA Link 03/2011 - 08/2003
3	Aromatase (CYP19)IBA 03/2011 - 08/2003
3	ProstaglandinsIBA 02/2009 - 08/2006
3	AndrogensIBA 02/2009 - 07/2002
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2007 - 02/2006
3	AntibodiesIBA 09/2002 - 04/2002
2	nutlin 3IBA 01/2022 - 01/2019
2	Tumor Suppressor Protein p53IBA 01/2022 - 01/2022
2	VitaminsIBA 11/2021 - 01/2020
2	AntioxidantsIBA 01/2021 - 10/2020
2	Olive OilIBA 01/2021 - 10/2020
2	morpholinopropane sulfonic acid (MOPS)IBA 01/2021 - 12/2020
2	NUPR1 inhibitor ZZW-115IBA 01/2021 - 01/2020
2	Alanine Transaminase (SGPT)IBA 10/2020 - 07/2015
2	oleocanthalIBA 10/2020 - 08/2017
2	CytokinesIBA 10/2020 - 02/2009
2	Vitamin D FDA LinkGeneric 05/2020 - 01/2015

Therapy/Procedure

39	Therapeutics 01/2022 - 06/2002
9	Drug Therapy (Chemotherapy) 01/2020 - 01/2004
3	Immunotherapy 01/2020 - 12/2006
2	Glycemic Control 01/2021 - 01/2014
2	Bariatric Surgery 12/2020 - 01/2020